SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs informs about trading window closure

19 Mar 2025 Evaluate
Vivimed Labs has informed that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Internal Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters and Designated Persons of the Company, the Trading Window would remain closed with effect from 01 .04.2025 till 48 hours after the declaration of the audited Financial Results of the Company for the quarter and year ended March 31, 2025 which becomes generally available information. The date of Board Meeting for declaration of the audited financial results of the Company for the quarter and year ended March 31, 2025 will be intimated in due course.

The above information is a part of company’s filings submitted to BSE.

Vivimed Labs Share Price

7.06 0.33 (4.90%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×